| Autor: |
Jacob, Anu Maria, Devarajan, Arutselvi, Nachimuthu, Sukanya, Datta, Manjula, Viswanathan, Vijay |
| Předmět: |
|
| Zdroj: |
International Journal of Diabetes in Developing Countries; Apr2023, Vol. 43 Issue 2, p208-213, 6p |
| Abstrakt: |
Background and aim: Diabetes has become a public health threat. The cost of diabetes care varies in different communities and depends on health-seeking behavior and socio-economic condition of the people. Data on economic and social impact of diabetes treatment among socially weaker section is scanty. Hence, this study was conducted to estimate the direct and indirect cost of treating diabetes among people living in low resource urban setting. Methods: A cross-sectional study was conducted among 1065 households in the two selected areas of North Chennai. Data was collected from individuals who were taking diabetes treatment in private health care facilities. The cost toward diabetes treatment for each participant was calculated using their medical bills, tablet strips and also self-reported cost details. Results: A total of 341 individuals were found to have diabetes and out of them, 230 (M:F, 63:167) individuals who attended private health facilities for their diabetes treatment were studied. Around 73% of them earned a monthly income of < INR 10,000. The study revealed that median annual direct cost of treating diabetes among the study participants was amounted to INR 7540. Annual median indirect cost amounted to INR 1650. Conclusion: People living with diabetes in low resource urban setting spent more toward direct medical cost. The out of pocket expenditure was mainly on hospitalization followed by medicines and investigations. The strengthening and provision of appropriate primary public health care services for diabetes in this setting may reduce out of pocket expenditure toward treatment of diabetes in private health care facilities. Highlights: • Nearly 3/4th of study participants who earn INR 10,000/month monitor their diabetes status rarely, but take medicines alone. • They spend INR 6000 on medicines annually while they spend only INR 400 on lab investigations. • More than 1/4th (28.3%) of them were irregular in taking medication and buying medicines with previous tablet strips from the medical shop. • Hypertension (24.7%) was the most common co-morbid condition prevalent among them than any other diabetic complications. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
